He, Yongzheng

c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions. [electronic resource] - PloS one 2012 - e46900 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1932-6203

10.1371/journal.pone.0046900 doi


Animals
Bone Resorption--drug therapy
Cell Adhesion--drug effects
Cell Movement--drug effects
Cells, Cultured
Enzyme Inhibitors--therapeutic use
Extracellular Signal-Regulated MAP Kinases--metabolism
Female
Gene Deletion
Humans
Macrophage Colony-Stimulating Factor--metabolism
Mice
Mice, Inbred C57BL
Neurofibromin 1--genetics
Osteoclasts--cytology
Osteoporosis--drug therapy
Receptor, Macrophage Colony-Stimulating Factor--antagonists & inhibitors
Ribosomal Protein S6 Kinases, 90-kDa--metabolism
Signal Transduction